U.S. approves new Merck drug for rare skin cancer
U.S. approves new Merck drug for rare skin cancer
Merck & Co Inc. won U.S. approval for a new drug to treat a rare and slow-growing skin cancer called advanced cutaneous T-cell lymphoma (CTCL), health officials said on Friday.
Vitamins and other supplements for the skin
KINNY SALAS - THE MOMENT I TURNED ON MY COMPUTER to write about my exciting, new and reasonably priced beauty discovery from Malaysia, I was surprised to see 300-plus messages on my inbox.
Not All Breast Cancers Involve Lump
Women should be aware that not every type of breast cancer reveals itself with a lump during self exams, says a U.S. expert. The most common symptoms of inflammatory breast cancer will be redness, swelling and sometimes pain, says Dr.
Satellites help ensure safe sunning
Excessive exposure to ultraviolet radiation is responsible for up to 60 000 deaths a year worldwide, according to a report released this summer by the World Health Organisation. Many of those deaths, however, could be avoided through simple preventive measures such as seeking shade when the UV Index is high, the report says.